Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials ; volume:9 ; number:1 ; day:8 ; month:11 ; year:2018 ; pages:1-9 ; date:12.2018
Stem cell research & therapy ; 9, Heft 1 (8.11.2018), 1-9, 12.2018
- Creator
-
Kleiderman, Erika
Boily, Audrey
Hasilo, Craig
Knoppers, Bartha Maria
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-018-1055-2
- URN
-
urn:nbn:de:101:1-2018122701024885312851
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kleiderman, Erika
- Boily, Audrey
- Hasilo, Craig
- Knoppers, Bartha Maria
- SpringerLink (Online service)
Other Objects (12)
Sample size calculation in multi-centre clinical trials
Overcoming the barriers to better evidence generation from clinical trials
Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
Overcoming Historicism
Overcoming Historicism
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
Regenerative supply chains : = Regenerative Wertschöpfungsketten
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Promising advances in clinical trials of dental tissue-derived cell-based regenerative medicine
Overcoming Culture Clash
Sample size calculation in multi-centre clinical trials
Overcoming the barriers to better evidence generation from clinical trials
Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
Overcoming Historicism
Overcoming Historicism
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
Regenerative supply chains : = Regenerative Wertschöpfungsketten
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Promising advances in clinical trials of dental tissue-derived cell-based regenerative medicine
Overcoming Culture Clash
Sample size calculation in multi-centre clinical trials
Overcoming the barriers to better evidence generation from clinical trials
Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?
Overcoming Historicism
Overcoming Historicism
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
Regenerative supply chains : = Regenerative Wertschöpfungsketten
Sample size calculation for multicentre efficacy trials of blood-stage malaria antigens
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
A systematic review of models to predict recruitment to multicentre clinical trials
Promising advances in clinical trials of dental tissue-derived cell-based regenerative medicine